Synapse - Raymond Comenzo

Results (115)

Export to EndNote / Excel | PubMed

Constraints on the pursuit of diagnostic confidence - Reply

Journal Article

Comenzo, R. L.
Blood (2006)

Fulltext@MSK | Save

Systemic immunoglobulin light-chain amyloidosis

Journal Article

Comenzo, R. L.
Clinical Lymphoma and Myeloma (2006)

Fulltext@MSK | Save

The serum free light chain ratio after one or two cycles of treatment is highly predictive of the magnitude of final response in patients undergoing initial treatment for multiple myeloma

Meeting Abstract

Hassoun, H.; Reich, L.; Klimek, V. M.; Dhodapkar, M.; Cohen, A.; Kewalramani, T.; Riedel, E. R.; Hedvat, C. V.; Teruya-Feldstein, J.; Filippa, D. A.; more...
Blood (2005)

Fulltext@MSK | Save

Plasma cell gene-expression profiles in patients with systemic AL amyloidosis: Responses to melphalan and stem cell transplant are associated with differential expression of genes involved in translation, protein degradation and detoxification

Meeting Abstract

Comenzo, R. L.; Zhou, P.; Wang, L. M.; Nimer, S. D.; Olshen, A. B.
Blood (2005)

Fulltext@MSK | Save

Seeking diagnostic confidence in typing amyloidosis: Prospective results with an algorithm to minimize misdiagnosis of immunoglobulin light-chain (AL) amyloidosis

Meeting Abstract

Comenzo, R. L.; Zhou, P.; Wang, L. M.; Clark, B. D.; Fleisher, M.; Teruya-Feldstein, J.
Blood (2005)

Fulltext@MSK | Save

Risk-adapted dosing of melphalan for systemic AL amyloidosis (AL) lowers treatment-related mortality: Early death but not post-3 month survival is linked to cardiac involvement

Meeting Abstract

Comenzo, R. L.; Zhou, P.; Hassoun, H.; Kewalramani, T.; Klimek, V.; Cohen, A. D.; Ferrand, S. K.; Dhodapkar, M.; Feldstein, J. T.; Fleisher, M.; more...
Blood (2005)

Fulltext@MSK | Save

Adjuvant dexamethasone (D)+/- thalidomide (T) improves hematologic and organ responses after risk-adapted high-dose melphalan with autologous stem cell transplant (SCT) for patients with systemic AL amyloidosis (AL)

Meeting Abstract

Cohen, A. D.; Zhou, P.; Reich, L.; Hassoun, H.; Teruya-Feldstein, J.; Filippa, D. A.; Fleisher, M.; Nimer, S. D.; Comenzo, R. L.
Blood (2005)

Fulltext@MSK | Save

Interim analysis of a phase II study of risk-adapted intravenous melphalan followed by adjuvant dexamethasone (D) and thalidomide (T) for newly diagnosed patients with systemic AL amyloidosis (AL)